OXYQUINOLINE: 122 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
Active Ingredient: OXYQUINOLINE SULFATE · Route: VAGINAL · Manufacturer: CooperSurgical, Inc. · HUMAN PRESCRIPTION DRUG · FDA Label: Available
First Report: 20130207 · Latest Report: 20250228
What Are the Most Common OXYQUINOLINE Side Effects?
All OXYQUINOLINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 96 | 78.7% | 44 | 58 |
| Pain | 81 | 66.4% | 45 | 55 |
| Joint swelling | 70 | 57.4% | 48 | 60 |
| Pulmonary embolism | 62 | 50.8% | 34 | 43 |
| Rheumatoid arthritis | 59 | 48.4% | 36 | 42 |
| Drug intolerance | 57 | 46.7% | 50 | 55 |
| Stomatitis | 56 | 45.9% | 52 | 55 |
| C-reactive protein increased | 55 | 45.1% | 45 | 49 |
| Urticaria | 55 | 45.1% | 52 | 55 |
| Apparent death | 53 | 43.4% | 34 | 43 |
| Deep vein thrombosis | 53 | 43.4% | 34 | 43 |
| Diverticulitis | 53 | 43.4% | 34 | 43 |
| Renal failure | 53 | 43.4% | 34 | 43 |
| Intentional product use issue | 52 | 42.6% | 48 | 52 |
| Arthropathy | 51 | 41.8% | 46 | 51 |
| Off label use | 51 | 41.8% | 39 | 47 |
| Drug hypersensitivity | 50 | 41.0% | 42 | 46 |
| Red blood cell sedimentation rate increased | 50 | 41.0% | 46 | 50 |
| C-reactive protein abnormal | 46 | 37.7% | 42 | 46 |
| Contraindicated product administered | 46 | 37.7% | 44 | 45 |
Who Reports OXYQUINOLINE Side Effects? Age & Gender Data
Gender: 57.6% female, 42.4% male. Average age: 51.4 years. Most reports from: CA. View detailed demographics →
Is OXYQUINOLINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 1 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
What Is OXYQUINOLINE Used For?
| Indication | Reports |
|---|---|
| Rheumatoid arthritis | 67 |
| Systemic lupus erythematosus | 48 |
| Product used for unknown indication | 41 |
OXYQUINOLINE vs Alternatives: Which Is Safer?
Official FDA Label for OXYQUINOLINE
Official prescribing information from the FDA-approved drug label.
Drug Description
P URPOSE OF TRIMO-SAN 1. To help restore and maintain normal vaginal acidity. 2. To coat walls of vagina with a lubricating film that may help reduce odor-causing bacteria, since bacteria can flourish in abnormal vaginal pH.
Warnings
W ARNING: Chemicals in various preparations can interact with the pessary material resulting in discoloration or deterioration of the pessary. TRIMO-SAN does not have a deleterious effect on any Milex pessary. Testing should be performed before using any other vaginal preparation with a pessary unless specifically prescribed by your healthcare professional.